Key result
Jugular vein distensibility ratio >1.6 identifies normal right atrial pressure and predicts ~57% fewer major events.
Why the study?
Clinical evaluation of central venous pressure is difficult, operator-dependent, and often inaccurate in patients with chronic advanced heart failure.
Does ultrasound-assessed jugular vein distensibility accurately identify normal right atrial pressure in patients with chronic advanced heart failure with reduced ejection fraction?
Cohort (n=201)
Does ultrasound-assessed jugular vein distensibility accurately identify normal right atrial pressure in patients with chronic advanced heart failure with reduced ejection fraction?
Ultrasound-assessed jugular vein distensibility (Valsalva-to-rest ratio >1.6) is a noninvasive tool that accurately identifies normal right atrial pressure and predicts better clinical outcomes in patients with advanced heart failure.
Supports noninvasive RAP estimation in advanced HFrEF; hypothesis-generating for risk stratification and requires prospective validation.
BACKGROUND: Clinical evaluation of central venous pressure is difficult, depends on experience, and is often inaccurate in patients with chronic advanced heart failure. We assessed the ultrasound-assessed internal jugular vein (JV) distensibility by ultrasound as a noninvasive tool to identify patients with normal right atrial pressure (RAP ≤7 mm Hg) in this population. METHODS: We measured JV distensibility as the Valsalva-to-rest ratio of the vein diameter in a calibration cohort (N=100) and a validation cohort (N=101) of consecutive patients with chronic heart failure with reduced ejection fraction who underwent pulmonary artery catheterization for advanced heart failure therapies workup. RESULTS: A JV distensibility threshold of 1.6 was identified as the most accurate to discriminate between patients with RAP ≤7 versus >7 mm Hg (area under the receiver operating characteristic curve, 0.74 [95% CI, 0.64–0.84]) and confirmed in the validation cohort (receiver operating characteristic, 0.82 [95% CI, 0.73–0.92]). A JV distensibility ratio >1.6 had predictive positive values of 0.86 and 0.94, respectively, to identify patients with RAP ≤7 mm Hg in the calibration and validation cohorts. Compared with patients from the calibration cohort with a high JV distensibility ratio (>1.6; n=42; median RAP, 4 mm Hg; pulmonary capillary wedge pressure, 11 mm Hg), those with a low JV distensibility ratio (≤1.6; n=58; median RAP, 8 mm Hg; pulmonary capillary wedge pressure, 22 mm Hg; P <0.0001 for both) were more likely to die or undergo a left ventricular assist device implant or heart transplantation (event rate at 2 years: 42.7% versus 18.2%; log-rank P =0.034). CONCLUSIONS: Ultrasound-assessed JV distensibility identifies patients with chronic advanced heart failure with normal RAP and better outcomes. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03874312.
No takes yet. Share an insight, caveat, or question.
Ammirati et al. (2024) conducted a cohort in Chronic heart failure with reduced ejection fraction (n=201). Ultrasound-assessed internal jugular vein (JV) distensibility vs. Low (≤1.6) vs high (>1.6) JV distensibility ratio was evaluated on Discrimination between patients with right atrial pressure ≤7 versus >7 mm Hg (validation cohort) (AUC 0.82, 95% CI 0.73-0.92).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: